Through ongoing collaboration, new companion diagnostic aims to deliver next-generation sequencing results in as little as 24 hours to help advance precision oncology.
https://www.pharmalive.com/wp-content/uploads/2023/01/ThermoFisher-AstraZeneca.jpg417475Administratorhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAdministrator2023-01-24 10:01:182023-01-24 10:02:23Thermo Fisher Scientific partners with AstraZeneca to develop solid tissue and blood-based companion diagnostic test for Tagrisso